Time to Tailor Surveillance Intervals of Nondysplastic Barrett ’s Esophagus According to Segment Length and Persistence Over Multiple Endoscopies

During the past 4 decades, there has been a rapid increase in the incidence of esophageal adenocarcinoma (EA), such that EA is one of the fastest increasing cancers in incidence among Western populations.1 Among white males in the United States, EA incidence has increased almost 10-fold and rates continue to increase.2 Strikingly, 40% of EA patients in the United States still are diagnosed with distant stage disease, and less than 20% of all EA patients survive for 5 years after EA diagnosis.2
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research